Cell & Gene Therapy

Working together to promote the clinical research and development process of innovative drugs and devices

Cell & Gene Therapy

GCP ClinPlus

With 20 years of experience in experimental research and trial management in the field of tumor treatment research, GCP ClinPlus has a unique advantage in the CRO industry.

Leader in customized oncology research and clinical trial solutions

GCP ClinPlus has conducted over 700 oncology studies, covering various stages of the development cycle from early approval to post market launch. In our study, oncology research accounted for approximately 40%, higher than any other therapeutic field. GCP ClinPlus addresses the unique challenges and complexities encountered in oncology trials through its innovative product and medical strategies. Our solution enables you to connect with industry experts with extensive experience in oncology. Whether it is a single center study or an expanded global research project, we will provide customized services based on the characteristics and requirements of your product, as well as future commercialization choices, to meet your clinical trial needs.

CGT success case field

Gene therapy (β - thalassemia, AAV vector gene therapy for ophthalmic diseases); Stem cells (acute graft-versus-host disease (aGVHD), etc.); CAR-T (relapsed/refractory multiple myeloma, primary liver cancer, etc.); Oncolytic virus; Non viral vector products; DC vaccines, etc.

Comprehensive solution

1) Reliable quality process control and data recording;

2) Fast project initiation and schedule;

3) Flexible strategies and response plans;

4) Assist the registration service and on-site verification service team for listing.